相似文献
1
Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities.
J Exp Med. 1973 Oct 1;138(4):1015-20. doi: 10.1084/jem.138.4.1015.
2
3
Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
Thromb Haemost. 1983 Aug 30;50(2):509-12.
4
Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
J Clin Invest. 1973 Nov;52(11):2708-16. doi: 10.1172/JCI107465.
5
A comparison of five different rabbit antisera to factor VIII and the demonstration of a factor VIII related antigen in normal and von Willebrand's disease platelets.
Thromb Res. 1974 Nov;5(5):585-99. doi: 10.1016/0049-3848(74)90049-8.
6
Letter: Willebrand-factor activity and antigen in von Willebrand's disease.
Lancet. 1974 Mar 23;1(7856):512-3. doi: 10.1016/s0140-6736(74)92824-4.
7
von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
J Clin Invest. 1978 Jun;61(6):1498-507. doi: 10.1172/JCI109070.
8
Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
N Engl J Med. 1978 May 4;298(18):988-91. doi: 10.1056/NEJM197805042981802.
9
Binding of low-molecular-weight canine factor VIII coagulant from von Willebrand plasma to canine factor VIII-related antigen.
Br J Haematol. 1981 Dec;49(4):541-50. doi: 10.1111/j.1365-2141.1981.tb07262.x.
10
[Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willerbrand's disease (author's transl)].
Pathol Biol (Paris). 1977 Dec;25 Suppl:18-24.
引用本文的文献
1
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.
Blood. 2016 Oct 20;128(16):2007-2016. doi: 10.1182/blood-2016-04-713289. Epub 2016 Sep 1.
2
The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.
J Clin Invest. 1974 Nov;54(5):1093-9. doi: 10.1172/JCI107853.
3
Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).
Proc Natl Acad Sci U S A. 1989 Jun;86(11):4277-81. doi: 10.1073/pnas.86.11.4277.
4
Factor-VIII-related antigen: multiple molecular forms in human plasma.
Proc Natl Acad Sci U S A. 1975 Dec;72(12):5121-5. doi: 10.1073/pnas.72.12.5121.
5
Presence of factor VIII-related antigen in blood platelets of patients with Von Willebrand's disease.
Nature. 1975 Oct 9;257(5526):510-12. doi: 10.1038/257510a0.
6
Problems in the detection of carriers of haemophilia A.
J Clin Pathol. 1975 Sep;28(9):690-5. doi: 10.1136/jcp.28.9.690.
7
Editorial: The hemophiloid diseases and factor VIII. Clinical molecular biology.
West J Med. 1975 May;122(5):423-4.
8
Medical staff conference: recent chapters in the factor VIII saga--perils of a protein. Fifth annual Paul M. Aggeler Memorial Lecture.
West J Med. 1975 May;122(5):406-16.
9
The properties of immune complexes formed by human antibodies to factor VIII.
J Clin Invest. 1977 Nov;60(5):1070-9. doi: 10.1172/JCI108858.
10
Interaction of factor VIII antigen in hemophilic plasmas with human antibodies to factor VIII.
J Clin Invest. 1977 May;59(5):984-9. doi: 10.1172/JCI108721.
本文引用的文献
1
Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.
J Clin Invest. 1971 Jan;50(1):244-54. doi: 10.1172/JCI106480.
2
Factor 8 detection by hemagglutination inhibition: hemophilia A and von Willebrand's disease.
Science. 1971 Jan 15;171(3967):196-7. doi: 10.1126/science.171.3967.196.
3
Selective enzyme purification by affinity chromatography.
Proc Natl Acad Sci U S A. 1968 Oct;61(2):636-43. doi: 10.1073/pnas.61.2.636.
4
Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen.
J Lab Clin Med. 1972 Dec;80(6):822-33.
5
Letter: Experimental model for von Willebrand's disease.
Nature. 1973 Jun 1;243(5405):293-4. doi: 10.1038/243293a0.
6
Ristocetin: a means of differentiating von Willebrand's disease into two groups.
Blood. 1973 May;41(5):687-90.
7
Two genetic variants of von Willebrand's disease.
N Engl J Med. 1973 Mar 22;288(12):595-8. doi: 10.1056/NEJM197303222881202.
8
Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate.
Am J Med. 1972 Dec;53(6):734-8. doi: 10.1016/0002-9343(72)90190-8.
9
Assay of the immune inhibitor in classic haemophilia: application of virus-antibody reaction kinetics.
Br J Haematol. 1972 May;22(5):517-28. doi: 10.1111/j.1365-2141.1972.tb05699.x.
10
Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia.
J Clin Invest. 1972 Oct;51(10):2597-601. doi: 10.1172/JCI107077.
Zotero 插件